Literature DB >> 33320289

Comparison of therapeutic efficacy and mechanism of paclitaxel alone or in combination with methotrexate in a collagen-induced arthritis rat model.

Z Sheng1, J Zeng2, W Huang3, L Li4, B Li3, C Lv3, F Yan3.   

Abstract

OBJECTIVE: To compare the therapeutic efficacy of paclitaxel (PTX) alone to its combination with methotrexate (MTX) on rheumatoid arthritis.
METHODS: A collagen-induced arthritis (CIA) rat model was established by induction of type II collagen. Rats were divided into blank control group, CIA model group, MTX group 1 mg/kg, PTX 1.5 mg/kg, PTX 2.5 mg/kg, PTX 3.5 mg/kg, and MTX 1 mg/kg + PTX 3.5 mg/kg, with 10 rats per group. The inflammation of the ankle joint was analyzed by H&E staining and interleukin (IL)-1β and IL‑6 expression was detected by immunohistochemistry. TUNEL assay was performed to detect synovial tissue cell apoptosis after administration of PTX and MTX either alone or in combination. TLR4 and p‑NF-κBp65 protein expression in synovial tissue and the changes of serum IL‑1β, IL‑6, IL‑12, MMP‑3, and TNFα protein factors were detected by western blot and ELISA, respectively.
RESULTS: PTX and MTX improved histopathological changes in CIA rats. Besides, the apoptosis rate of synovial tissue cells in the PTX 3.5 mg/kg group was more than that of the PTX + MTX group. Immunohistochemistry and western blot results indicated that PTX and MTX reduce the expression rate of IL‑6 and IL‑1β and downregulate TLR4 and p‑NF-κBp65 protein expression. Furthermore, TLR4 and p‑NF-κBp65 reduced the concentration of MMP‑3, IL‑12, IL‑6, IL1‑β, and TNFα.
CONCLUSION: Both PTX and MTX exert significant suppression on rheumatoid arthritis, and the combined effect of the two drugs is weaker than that of PTX alone. Moreover, intraperitoneal injection of PTX 3.5 mg/kg every other day was the optimal dose observed in this study.
© 2020. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Combination therapy; Rheumatoid arthritis; TLR4; Type II collagen; p‑NF-κBp65

Mesh:

Substances:

Year:  2020        PMID: 33320289     DOI: 10.1007/s00393-020-00940-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  3 in total

Review 1.  Geriatric syndromes in patients with rheumatoid arthritis: a literature overview.

Authors:  Fiona A H M Cleutjens; Annelies E R C H Boonen; Marloes G B van Onna
Journal:  Clin Exp Rheumatol       Date:  2018-12-19       Impact factor: 4.473

2.  Combination of B cell biomarkers as independent predictors of response in patients with rheumatoid arthritis treated with rituximab.

Authors:  H-P Tony; P Roll; H E Mei; E Blümner; A Straka; L Gnuegge; T Dörner
Journal:  Clin Exp Rheumatol       Date:  2015-10-30       Impact factor: 4.473

3.  Paclitaxel suppresses collagen-induced arthritis: a reevaluation.

Authors:  Yi Zhao; Zhi-Fang Chang; Ru Li; Zhan-Guo Li; Xiao-Xia Li; Lin Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.